Transforming the United States Generics Market

Driven to cure. Empowered to deliver

In the United States, 9 out of 10 prescriptions are generic, yet shortages, and quality gaps persist. Aryeh was created to change that. Backed by BDR’s 20+ year global legacy, Aryeh is built for the U.S. market, restoring trust, ensuring quality, and expanding access to essential medicines.

Committed to access. Grounded in compliance.

Note: Aryeh products meet FDA quality standards; please refer to individual product pages for indications.

Backed by BDR Pharma FDA-aligned Gold standard 150+ Products Backed by BDR Pharma FDA-aligned Gold standard 150+ Products
Backed by BDR Pharma FDA-aligned Gold standard 150+ Products Backed by BDR Pharma FDA-aligned Gold standard 150+ Products

ARYEH’S PROMISE

The Aryeh Pharmaceuticals Advantage: Where Courage Meets Compliance

At Aryeh, every decision is rooted in bold innovation, uncompromising quality, and patient-first thinking. Discover how our values shape a new standard in generics, built for trust, access, and lasting impact.

Courage to Challenge

We question conventional approaches to generic development, pricing, and delivery, driving innovation that always puts patients first.

Strength in Reliability

Our gold-standard manufacturing systems are designed to exceed FDA and GMP expectations, ensuring consistent quality and dependable supply.

Guardianship of Access

Every decision prioritizes patient access, making life-saving therapies affordable without compromising quality.

Precision in Execution

Through a strategic 3-track model and world-class partnerships, Aryeh is building a broad and impactful generics portfolio for the U.S. market.

LEGACY & CREDIBILITY

Backed by BDR’s Global Legacy

Built on the global legacy of BDR Pharmaceuticals and designed specifically for the U.S. market, Aryeh is not just another generics company. It is a bold, values-driven organization created to restore trust and set a higher standard in generics.

Since 2003, BDR Pharmaceuticals has pioneered accessible healthcare across 30+ countries under the visionary leadership of Mr. Dharmesh Shah. With two decades of commitment to innovation, affordability, and ethical practices, BDR has become a trusted name in regulated markets worldwide

KEY ACHIEVEMENTS:

Global presence across 30+ countries with a workforce of 2,000+ professionals

R&D specialists driving innovation in complex generics

24 state-of-the-art manufacturing and development facilities with integrated API-to-formulation capabilities

Strong regulatory track record with approvals across the U.S., EU, and key emerging markets

50% of products are blockbuster drug generics, including multiple first-to-market launches

Why Choose Us

Designed for United States Impact: Global Strength, Local Precision

Aryeh combines BDR’s world-class pharmaceutical legacy with a U.S.-focused, agile operating model built for speed, compliance, and reliability. Our lean, expert team is designed to deliver bold innovation and regulatory excellence, with direct FDA engagement and a portfolio tailored to high-impact therapeutic categories.

OUR UNITED STATES ADVANTAGE:

Purpose-built legal and operational entity

Direct FDA and regulatory body engagement

Lean 35–40 person team ensuring maximum agility

Three-phase launch strategy with clear milestones

Strong therapeutic focus on oncology, critical care, and other high-value segments

STRATEGIC APPROACH

Our Three-Track Strategic Engine

A comprehensive approach combining innovation, partnerships, and manufacturing excellence.

IN-HOUSE DEVELOPMENT

High-impact therapies where control and differentiation matter most

→ Complex molecules, proprietary formulations

IN-LICENSING

Proven products for rapid market entry and portfolio depth

→ Strategic partnerships, accelerated timelines

CDMO PARTNERSHIPS

Top-tier manufacturing relationships ensuring scalable, reliable supply

→ Lean operations, quality assurance

THERAPEUTIC CATEGORIES

Therapeutic Excellence Across Critical Healthcare Needs

Oncology Solutions
Critical Care
Cardiovascular Health
Dermatology Care
Oncology Solutions

Advanced cancer care therapies targeting unmet medical needs

  • 40+ specialized oncology formulations
  • Complex injectables and targeted delivery
  • First-to-market opportunities in emerging therapies
Critical Care

Life-saving treatments for emergency and intensive care settings

  • Essential hospital-grade medications
  • Emergency cardiac and respiratory support
  • 24/7 supply reliability for critical situations
Cardiovascular Health

Comprehensive cardiac care and chronic disease management

  • Proven heart health formulations
  • Hypertension and cholesterol management
  • Long-term patient outcome focus
Dermatology & Specialized Care

Advanced skin health and therapeutic dermatology solutions

  • Prescription and specialty OTC options
  • Innovative delivery systems (foams, creams, gels)
  • Dermatologist-trusted formulations

QUALITY & COMPLIANCE

Gold-Standard Excellence: Built for FDA Success

Aryeh's gold-standard quality systems are designed specifically for FDA success, combining proactive regulatory engagement with world-class GMP manufacturing capabilities. Our integrated infrastructure ensures every product meets the highest safety and efficacy standards while maintaining reliable supply to healthcare providers nationwide. Built on two decades of global regulatory expertise, we deliver the precision and compliance excellence the U.S. market requires.

FDA COMPLIANCE

Proactive regulatory engagement ensuring streamlined FDA approvals.

  • 21 CFR Part 211 GMP compliance systems
  • Pre-submission meetings and regulatory strategy development
  • Direct FDA communication channels for expedited resolution

GMP MANUFACTURING

World-class quality systems built to exceed FDA expectations.

  • Integrated API-to-formulation capabilities ensuring complete control
  • Real-time release testing and continuous process monitoring
  • ICH Q10 pharmaceutical quality system implementation

SUPPLY RELIABILITY

Resilient distribution networks designed for U.S. market demands.

  • Multi-tier supply chain redundancy preventing disruptions
  • Strategic inventory management ensuring consistent availability
  • 24/7 emergency response protocols for critical medicine access

CLINICAL EXCELLENCE

Advanced R&D capabilities driving complex generic development.

  • 90+ specialized scientists with regulatory submission expertise
  • Strategic inventory management ensuring consistent availability
  • Bioequivalence study management for complex dosage forms

Ready to Partner with Purpose

Driven by Values, Delivering Transformative Medicines

Aryeh is purpose-built for the United States, combining BDR’s global legacy with a bold United States focused mission to restore trust, ensure quality, and expand patient access to critical generics.